SFRP2 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q96HF1 |
---|---|
Clone Names | 100311243 |
Gene ID | 6423 |
---|---|
Other Names | Secreted frizzled-related protein 2, FRP-2, sFRP-2, Secreted apoptosis-related protein 1, SARP-1, SFRP2, FRP2, SARP1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SFRP2 |
---|---|
Synonyms | FRP2, SARP1 |
Function | Soluble frizzled-related proteins (sFRPS) function as modulators of Wnt signaling through direct interaction with Wnts. They have a role in regulating cell growth and differentiation in specific cell types. SFRP2 may be important for eye retinal development and for myogenesis. |
Cellular Location | Secreted. |
Tissue Location | Expressed in adipose tissue, heart, brain, skeletal muscle, pancreas, thymus, prostate, testis, ovary, small intestine and colon. Highest levels in adipose tissue, small intestine and colon |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the SFRP family thatcontains a cysteine-rich domain homologous to the putativeWnt-binding site of Frizzled proteins. SFRPs act as solublemodulators of Wnt signaling. Methylation of this gene is apotential marker for the presence of colorectal cancer. [providedby RefSeq].
References
von Marschall, Z., et al. Biochem. Biophys. Res. Commun. 400(3):299-304(2010)Pehlivan, S., et al. Cancer Genet. Cytogenet. 201(2):128-132(2010)Kohno, H., et al. Oncol. Rep. 24(2):423-431(2010)Yamamura, S., et al. Mol. Cancer Ther. 9(6):1680-1687(2010)Forsman, H., et al. BMC Cell Biol. 11, 52 (2010) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.